Study ID: CA43-ACT16852 for Hidradenitis Supperativa
Summary
Simcoderm Clinical Trials is recruiting adults who are 18 to 70 years of age, inclusive with a history of signs and symptoms consistent with hidradenitis suppurativa (HS) for at
least 1 year, to participate in this clinical research trial.
Participants will receive investigational injected treatment (active study drug) or placebo.
Must have HS lesions present in at least 2 distinct anatomic areas, have a total abscess and inflammatory nodule (AN) count of 3 or more, and a draining tunnel (fistula) count of 20 or less.
In addition, individuals must have had an inadequate response to a trial of an oral antibiotic for treatment of HS, or exhibited recurrence after discontinuation of antibiotics, or demonstrated intolerance to antibiotics, or have a contraindication to oral antibiotics for treatment of their HS.
Other eligibility criteria apply.
Participants will receive investigational treatment (active study drug) or placebo, via injection. Beginning at the Week 16 visit, all participants will receive active study drug. Study treatment and study-related assessments will be provided at no cost.
Reimbursement for study-related expenses will also be provided.
Study participation will last about 40 weeks and involve about 17 visits to the study centre.
Study Details
| Study Name | Age Requirements | Length of Study | Type of Treatment |
|---|---|---|---|
CA43-ACT16852 | 18-70 | 40 Weeks.
(17 visits to the clinic) | Injection |
Simcoderm Clinical Trials is recruiting adults who are 18 to 70 years of age, inclusive with a history of signs and symptoms consistent with hidradenitis suppurativa (HS) for at
least 1 year, to participate in this clinical research trial.
Participants will receive investigational injected treatment (active study drug) or placebo.
Must have HS lesions present in at least 2 distinct anatomic areas, have a total abscess and inflammatory nodule (AN) count of 3 or more, and a draining tunnel (fistula) count of 20 or less.
In addition, individuals must have had an inadequate response to a trial of an oral antibiotic for treatment of HS, or exhibited recurrence after discontinuation of antibiotics, or demonstrated intolerance to antibiotics, or have a contraindication to oral antibiotics for treatment of their HS.
Other eligibility criteria apply.
Participants will receive investigational treatment (active study drug) or placebo, via injection. Beginning at the Week 16 visit, all participants will receive active study drug. Study treatment and study-related assessments will be provided at no cost.
Reimbursement for study-related expenses will also be provided.
Study participation will last about 40 weeks and involve about 17 visits to the study centre.
Contact us about joining the trial
To be eligible for this trial, applicants MUST have a skin condition. We DO NOT accept volunteers who do not have a skin disease.
Fill out this form to get in touch or call our trial line at # (289)-763-8666 . We will contact you in 1-2 business days regarding your application to participate in the trial.
Privacy Policy for SimcoDerm Clinical Trials
Your privacy is important to us, and we take the protection of your personal health information (PHI) seriously. This policy explains how we collect, use, and protect your information.
We collect information directly from you, including your name, contact details, health information, and treatment history.
We use your information to determine eligibility for clinical trials, manage appointments, and communicate with you about your participation in clinical trials.
Data Protection:
Your information is stored securely and is only accessible by authorized personnel. We use data encryption, conduct security audits, and implement strict access controls to ensure the protection of your personal information.
You have the right to access, amend, or request the deletion of your health records. To exercise these rights, send a request to our clinical trial support team.